ThermoFisher (TMO) Offering Possible 27.39% Return Over the Next 14 Calendar Days

This post was originally published on this site

ThermoFisher’s most recent trend suggests a bullish bias. One trading opportunity on ThermoFisher is a Bull Put Spread using a strike $550.00 short put and a strike $530.00 long put offers a potential 27.39% return on risk over the next 14 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $550.00 by expiration. The full premium credit of $4.30 would be kept by the premium seller. The risk of $15.70 would be incurred if the stock dropped below the $530.00 long put strike price.

The 5-day moving average is moving up which suggests that the short-term momentum for ThermoFisher is bullish and the probability of a rise in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for ThermoFisher is bullish.

The RSI indicator is at 63.07 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here

LATEST NEWS for ThermoFisher

Thermo Fisher Scientific (TMO) Outpaces Stock Market Gains: What You Should Know
Wed, 01 Sep 2021 21:50:09 +0000
Thermo Fisher Scientific (TMO) closed the most recent trading day at $561.72, moving +1.22% from the previous trading session.

Top Stock Reports for Adobe, Thermo Fisher & BHP Group
Tue, 31 Aug 2021 17:15:05 +0000
Today’s Research Daily features new research reports on 16 major stocks, including Adobe Inc. (ADBE), Thermo Fisher Scientific Inc. (TMO), and BHP Group (BHP).

Why Is Thermo Fisher (TMO) Up 3.6% Since Last Earnings Report?
Fri, 27 Aug 2021 15:31:03 +0000
Thermo Fisher (TMO) reported earnings 30 days ago. What’s next for the stock? We take a look at earnings estimates for some clues.

Thermo Fisher’s (TMO) Oncomine Dx Gets CDx Approval for TIBSOVO
Fri, 27 Aug 2021 13:18:01 +0000
Thermo Fisher (TMO) receives FDA go-ahead for the Oncomine Dx Target Test as a CDx for Servier’s ivosidenib tablets, TIBSOVO.

Thermo Fisher Scientific (TMO) Gains As Market Dips: What You Should Know
Thu, 26 Aug 2021 21:50:09 +0000
Thermo Fisher Scientific (TMO) closed at $552.77 in the latest trading session, marking a +0.86% move from the prior day.

Be Sociable, Share!

Related Posts